Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Warfarin prophylaxis after total knee arthroplasty.

J R Lieberman1

  • 1Department of Orthopedic Surgery, UCLA Medical Center, Los Angeles, California 90024-3010, USA.

The American Journal of Knee Surgery
|March 2, 1999
PubMed
Summary

Low-dose warfarin offers safe oral prophylaxis after total knee arthroplasty (TKA). However, careful INR monitoring is crucial, and further study is needed on early protection and asymptomatic clot impacts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AOA Critical Issues Symposium: So, You Want to Be a Department Leader: Essentials for Success.

The Journal of bone and joint surgery. American volume·2024
Same author

Trends in the use of dual mobility bearings in hip arthroplasty.

The bone & joint journal·2020
Same author

The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur.

Gene therapy·2015
Same author

A comparison of the incidence of complications following total hip arthroplasty in patients with or without osteonecrosis.

The Journal of arthroplasty·2014
Same author

Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery.

Global spine journal·2013
Same author

Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.

Gene therapy·2013

Area of Science:

  • Orthopedic Surgery
  • Pharmacology
  • Vascular Medicine

Background:

  • Low-dose warfarin is a safe and effective oral prophylactic agent post-total knee arthroplasty (TKA).
  • Oral administration is a significant advantage for patient convenience.
  • Concerns exist regarding patient protection in the early perioperative period and the impact of asymptomatic clots.

Purpose of the Study:

  • To evaluate the efficacy and safety of low-dose warfarin prophylaxis after TKA.
  • To address concerns about early perioperative protection.
  • To investigate the long-term effects of asymptomatic clot formation on venous stasis disease.

Main Methods:

  • Administration of 2 weeks of deep vein thrombosis (DVT) prophylaxis post-TKA.
  • Oral warfarin regimen with required International Normalized Ratio (INR) monitoring.
  • Exclusion of routine ultrasonography screening for DVT.

Main Results:

  • Low-dose warfarin demonstrated safe and effective prophylaxis in TKA patients.
  • Oral administration facilitated patient compliance.
  • INR monitoring necessitates careful management to ensure adequate anticoagulation.

Conclusions:

  • Low-dose warfarin is a viable prophylactic option after TKA.
  • Further research is required to fully understand the implications of asymptomatic clot formation.
  • The current protocol involves a 2-week DVT prophylaxis period without routine ultrasonography.

Related Experiment Videos